BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 21975388)

  • 1. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.
    Xiangsong Z; Xingchong S; Chang Y; Xiaoyan W; Zhifeng C
    Clin Nucl Med; 2011 Nov; 36(11):1003-6. PubMed ID: 21975388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-11C-acetate versus 18F-FDG PET in detection of meningioma and monitoring the effect of gamma-knife radiosurgery.
    Liu RS; Chang CP; Guo WY; Pan DH; Ho DM; Chang CW; Yang BH; Wu LC; Yeh SH
    J Nucl Med; 2010 Jun; 51(6):883-91. PubMed ID: 20484430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-11 choline versus F-18 fluorodeoxyglucose for imaging meningiomas: an initial experience.
    Giovacchini G; Fallanca F; Landoni C; Gianolli L; Picozzi P; Attuati L; Terreni M; Picchio M; Messa C; Fazio F
    Clin Nucl Med; 2009 Jan; 34(1):7-10. PubMed ID: 19092373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of
    Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y
    Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET.
    Cremerius U; Bares R; Weis J; Sabri O; Mull M; Schröder JM; Gilsbach JM; Buell U
    J Nucl Med; 1997 Jan; 38(1):26-30. PubMed ID: 8998144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Meningioma WHO Grade Using PET Findings: A Systematic Review and Meta-Analysis.
    Slot KM; Verbaan D; Buis DR; Schoonmade LJ; Berckel BNM; Vandertop WP
    J Neuroimaging; 2021 Jan; 31(1):6-19. PubMed ID: 33135239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 111indium-octreotide brain scintigraphy in the diagnosis of cranial, dural-based meningiomas.
    Nathoo N; Ugokwe K; Chang AS; Li L; Ross J; Suh JH; Vogelbaum MA; Barnett GH
    J Neurooncol; 2007 Jan; 81(2):167-74. PubMed ID: 16850106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [
    Tosaka M; Higuchi T; Horiguchi K; Osawa T; Arisaka Y; Fujita H; Tsushima Y; Yoshimoto Y
    World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
    Tomura N; Saginoya T; Goto H
    J Comput Assist Tomogr; 2018; 42(4):517-521. PubMed ID: 29613985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by
    Ding L; Zhang F; He Q; Li Z; Shi X; Li R; Zhang X
    BMC Cancer; 2020 Jun; 20(1):564. PubMed ID: 32552842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of meningiomas assessed by ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron-emission tomography.
    Arita H; Kinoshita M; Okita Y; Hirayama R; Watabe T; Ishohashi K; Kijima N; Kagawa N; Fujimoto Y; Kishima H; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
    J Neurooncol; 2012 Apr; 107(2):379-86. PubMed ID: 22089887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.
    Di Chiro G; Hatazawa J; Katz DA; Rizzoli HV; De Michele DJ
    Radiology; 1987 Aug; 164(2):521-6. PubMed ID: 3496626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grading meningioma: a comparative study of thallium-SPECT and FDG-PET.
    Okuchi S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Yamauchi M; Kataoka M; Arakawa Y; Takahashi JC; Minamiguchi S; Miyamoto S; Togashi K
    Medicine (Baltimore); 2015 Feb; 94(6):e549. PubMed ID: 25674763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma.
    Li D; Zhang J; Ji N; Zhao X; Zheng K; Qiao Z; Li F; Lang L; Iagaru A; Niu G; Zhu Z; Chen X
    Clin Nucl Med; 2018 Sep; 43(9):648-654. PubMed ID: 30052597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
    Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
    Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion-metabolism coupling in recurrent gliomas: a prospective validation study with 13N-ammonia and 18F-fluorodeoxyglucose PET/CT.
    Khangembam BC; Karunanithi S; Sharma P; Kc SS; Kumar R; Julka PK; Kumar R; Bal C
    Neuroradiology; 2014 Oct; 56(10):893-902. PubMed ID: 24989883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of meningioma aggressiveness by (99m)Tc-Tetrofosmin SPECT.
    Alexiou GA; Vartholomatos G; Tsiouris S; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Voulgaris S; Fotopoulos AD
    Clin Neurol Neurosurg; 2008 Jul; 110(7):645-8. PubMed ID: 18471956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and tracer kinetics of O-(2-(18)F-fluoroethyl)-L-tyrosine in meningiomas: preliminary results.
    Cornelius JF; Stoffels G; Filß C; Galldiks N; Slotty P; Kamp M; el Khatib M; Hänggi D; Sabel M; Felsberg J; Steiger HJ; Coenen HH; Shah NJ; Langen KJ
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):459-67. PubMed ID: 25331459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of (13)N-NH (3) PET in the evaluation of brain lesions that are hypometabolic on (18)F-FDG PET.
    Xiangsong Z; Weian C; Dianchao Y; Xiaoyan W; Zhifeng C; Xiongchong S
    J Neurooncol; 2011 Oct; 105(1):103-7. PubMed ID: 21503829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18FDG-PET in intracranial meningiomas versus grading, proliferation index, cellular density and cytogenetic analysis].
    Cremerius U; Striepecke E; Henn W; Weis J; Mull M; Lippitz B; Gilsbach J; Schröder JM; Zang KD; Böcking A
    Nuklearmedizin; 1994 Aug; 33(4):144-9. PubMed ID: 7971289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.